Navigating the changing multiple myeloma treatment landscape: clinical practice patterns of MM patients treated in- and outside German DSMM study group trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Navigating the changing multiple myeloma treatment landscape: clinical practice patterns of MM patients treated in- and outside German DSMM study group trials

Published:2018-03-23 Issue:11 Volume:59 Page:2692-2699
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Gengenbach Laura¹,Reinhardt Heike¹,Ihorst Gabriele²,Ajayi Stefanie¹³,Dold Sandra Maria¹,Köhler Martin¹,Einsele Hermann⁴,Duyster Justus¹³,Wäsch Ralph¹³,Engelhardt Monika¹³

Affiliation:

1. Department of Hematology, Oncology, Stem Cell Transplantation, University Medical Center Freiburg, Freiburg, Germany;

2. Clinical Trials Unit, University Medical Center Freiburg, Freiburg, Germany;

3. Comprehensive Cancer Center Freiburg (CCCF), University Medical Center Freiburg, Freiburg, Germany;

4. Medizinische Klinik und Poliklinik II, Klinikum der Bayrischen Julius-Maximilians-Universität, Würzburg, Germany

Funder

German Cancer Aid

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2018.1448084

Reference26 articles.

1. Is immunotherapy here to stay in multiple myeloma?

2. Multidisziplinäre Tumorboards: Fakten und Zufriedenheitsanalyse eines unverzichtbaren Instruments von Tumorzentren

3. Patterns of Improved Survival in Patients With Multiple Myeloma in the Twenty-First Century: A Population-Based Study

4. Analysis of Real-World Data on Overall Survival in Multiple Myeloma Patients With ≥3 Prior Lines of Therapy Including a Proteasome Inhibitor (PI) and an Immunomodulatory Drug (IMiD), or Double Refractory to a PI and an IMiD

5. Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drivers of physician decision-making and patient perspectives across lines of therapy in multiple myeloma in the USA;Future Oncology;2023-07

2. Multidisciplinary tumor board analysis: validation study of a central tool in tumor centers;Annals of Hematology;2022-12-05

3. Choosing the Right Therapy for Patients with Relapsed/Refractory Multiple Myeloma (RRMM) in Consideration of Patient-, Disease- and Treatment-Related Factors;Cancers;2021-08-26

4. Physical activity is associated with less comorbidity, better treatment tolerance and improved response in patients with multiple myeloma undergoing stem cell transplantation;Journal of Geriatric Oncology;2021-05

5. Survival and treatment patterns of patients with relapsed or refractory multiple myeloma in France — a cohort study using the French National Healthcare database (SNDS);Annals of Hematology;2021-04-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3